LivingGLP1
Study S002599

An Open-label, Randomized Controlled Pilot Study Evaluating the Impact of a Prebiotic Soda on Gastrointestinal Symptoms in Users of GLP-1 Agonists

Registration

Registration
NCT07744360
Study type
INTERVENTIONAL
Allocation
RANDOMIZED
Masking
NONE
Status
COMPLETED
Enrollment
80
Start
2026-02-10
Primary completion
2026-05-04
Lead sponsor
Olipop, PBC
Conditions
GI Symptoms
Interventions
OTHER:Prebiotic Soda
Results posted
FALSE
Individual participant data sharing
NO

Registered primary outcomes

  • Evaluate the impact of a prebiotic soda on gastrointestinal (GI) symptoms in users of GLP-1 agonists [Baseline, week 1, week 2, and week 4]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.